4 February 2026, 01:24 PM
The report presents a comprehensive analysis of the global gastric balloon market, focusing on market value, growth rate, and future projections. It evaluates market performance between 2025 and 2034 and explains factors supporting market expansion. The study also reviews regional developments and company participation, helping stakeholders understand future market direction and growth potential.
𝐌𝐚𝐫𝐤𝐞𝐭 𝐒𝐢𝐳𝐞 𝐚𝐧𝐝 𝐅𝐨𝐫𝐞𝐜𝐚𝐬𝐭
The gastric balloon market was valued at USD 1.93 billion in 2025 and is projected to grow to USD 2.18 billion in 2026. The market is expected to reach USD 5.95 billion by 2034, registering a CAGR of 13.34% during the forecast period. Growth is driven by rising obesity levels, increasing demand for non-surgical weight loss options, and growing awareness of minimally invasive treatments.
The report provides insights into market growth trends, long-term outlook, and overall industry development. It examines regional performance and competitive presence. The study also supports strategic planning with clear market estimates and forecast data.
𝐌𝐚𝐫𝐤𝐞𝐭 𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧
The market is segmented by product type, application, end-user, patient demographics, and distribution channel. This segmentation helps explain how gastric balloon solutions are designed, applied, and delivered. It provides a structured view of market usage and industry organization.
𝐁𝐲 𝐏𝐫𝐨𝐝𝐮𝐜𝐭 𝐓𝐲𝐩𝐞
This segment focuses on different gastric balloon designs used in weight management.
• Saline-filled Gastric Balloons: Filled with saline to create a feeling of fullness and support controlled weight loss.
• Gastric Balloons for Flavored Fill: Designed with flavored solutions to improve patient comfort.
• Non-surgical Gastric Balloons: Used without surgery, offering a minimally invasive treatment option.
• Adjustable Gastric Balloons: Allows volume adjustment during treatment for better results.
𝐁𝐲 𝐀𝐩𝐩𝐥𝐢𝐜𝐚𝐭𝐢𝐨𝐧
This segment explains the medical and wellness uses of gastric balloons.
• Weight Loss: Used in structured programs to support gradual weight reduction.
• Pre-operative Weight Loss for Bariatric Surgery: Helps patients reduce weight before surgical procedures.
• Gastroesophageal Reflux Disease Management: Used in selected cases for symptom management.
• Other Gastrointestinal Disorders: Includes additional digestive health applications.
𝐁𝐲 𝐄𝐧𝐝-𝐔𝐬𝐞𝐫
This segment highlights healthcare settings where gastric balloon procedures are performed.
• Hospitals: Provide monitored treatment and follow-up care.
• Specialized Clinics: Focus on targeted weight management services.
• Ambulatory Surgical Centers: Offer outpatient treatment options.
• Weight-loss Centers: Deliver non-surgical weight management programs.
𝐁𝐲 𝐏𝐚𝐭𝐢𝐞𝐧𝐭 𝐃𝐞𝐦𝐨𝐠𝐫𝐚𝐩𝐡𝐢𝐜𝐬
This segment focuses on age and gender-based patient groups.
• Adults (18–65 Years): Primary users seeking weight management solutions.
• Adolescents (Under 18 Years): Limited usage under medical supervision.
• Senior Citizens (65 Years and Older): Used with careful health evaluation.
• Gender-specific Male: Treatments tailored for male patients.
• Gender-specific Female: Treatments designed for female patient needs.
𝐁𝐲 𝐃𝐢𝐬𝐭𝐫𝐢𝐛𝐮𝐭𝐢𝐨𝐧 𝐂𝐡𝐚𝐧𝐧𝐞𝐥
This segment explains how products reach healthcare providers and patients.
• Direct Sales: Manufacturers supply products directly to medical facilities.
• Online Retail: Enables digital purchasing and product access.
• Dealerships: Act as regional sales and service partners.
• Distributors and Wholesalers: Manage large-scale product distribution.
𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬
The market is competitive, with companies focusing on product innovation and expanding treatment availability.
• Apollo Endosurgery Inc.: Develops minimally invasive weight loss solutions.
• Obalon Therapeutics Inc.: Focuses on swallowable gastric balloon systems.
• Allurion Technologies Inc.: Specializes in non-surgical gastric balloon treatments.
• Spatz FGIA: Offers adjustable gastric balloon technologies.
• ReShape Medical Inc.: Provides integrated weight loss solutions.
Companies are focusing on innovation, product improvement, and expanding clinical adoption.
𝐑𝐞𝐠𝐢𝐨𝐧𝐚𝐥 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬
The market shows steady growth across major global regions.
• North America: Driven by high obesity prevalence and strong healthcare infrastructure.
• Europe: Supported by increasing awareness of non-surgical weight loss options.
• Asia-Pacific: Growing due to rising obesity levels and improving healthcare access.
• Latin America: Gradual growth with increasing focus on weight management.
• Middle East & Africa: Developing steadily with expanding healthcare services.
𝐈𝐧𝐟𝐨𝐫𝐦𝐚𝐭𝐢𝐨𝐧 𝐒𝐨𝐮𝐫𝐜𝐞: https://www.valuemarketresearch.com/repo...oon-market
𝐌𝐚𝐫𝐤𝐞𝐭 𝐒𝐢𝐳𝐞 𝐚𝐧𝐝 𝐅𝐨𝐫𝐞𝐜𝐚𝐬𝐭
The gastric balloon market was valued at USD 1.93 billion in 2025 and is projected to grow to USD 2.18 billion in 2026. The market is expected to reach USD 5.95 billion by 2034, registering a CAGR of 13.34% during the forecast period. Growth is driven by rising obesity levels, increasing demand for non-surgical weight loss options, and growing awareness of minimally invasive treatments.
The report provides insights into market growth trends, long-term outlook, and overall industry development. It examines regional performance and competitive presence. The study also supports strategic planning with clear market estimates and forecast data.
𝐌𝐚𝐫𝐤𝐞𝐭 𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧
The market is segmented by product type, application, end-user, patient demographics, and distribution channel. This segmentation helps explain how gastric balloon solutions are designed, applied, and delivered. It provides a structured view of market usage and industry organization.
𝐁𝐲 𝐏𝐫𝐨𝐝𝐮𝐜𝐭 𝐓𝐲𝐩𝐞
This segment focuses on different gastric balloon designs used in weight management.
• Saline-filled Gastric Balloons: Filled with saline to create a feeling of fullness and support controlled weight loss.
• Gastric Balloons for Flavored Fill: Designed with flavored solutions to improve patient comfort.
• Non-surgical Gastric Balloons: Used without surgery, offering a minimally invasive treatment option.
• Adjustable Gastric Balloons: Allows volume adjustment during treatment for better results.
𝐁𝐲 𝐀𝐩𝐩𝐥𝐢𝐜𝐚𝐭𝐢𝐨𝐧
This segment explains the medical and wellness uses of gastric balloons.
• Weight Loss: Used in structured programs to support gradual weight reduction.
• Pre-operative Weight Loss for Bariatric Surgery: Helps patients reduce weight before surgical procedures.
• Gastroesophageal Reflux Disease Management: Used in selected cases for symptom management.
• Other Gastrointestinal Disorders: Includes additional digestive health applications.
𝐁𝐲 𝐄𝐧𝐝-𝐔𝐬𝐞𝐫
This segment highlights healthcare settings where gastric balloon procedures are performed.
• Hospitals: Provide monitored treatment and follow-up care.
• Specialized Clinics: Focus on targeted weight management services.
• Ambulatory Surgical Centers: Offer outpatient treatment options.
• Weight-loss Centers: Deliver non-surgical weight management programs.
𝐁𝐲 𝐏𝐚𝐭𝐢𝐞𝐧𝐭 𝐃𝐞𝐦𝐨𝐠𝐫𝐚𝐩𝐡𝐢𝐜𝐬
This segment focuses on age and gender-based patient groups.
• Adults (18–65 Years): Primary users seeking weight management solutions.
• Adolescents (Under 18 Years): Limited usage under medical supervision.
• Senior Citizens (65 Years and Older): Used with careful health evaluation.
• Gender-specific Male: Treatments tailored for male patients.
• Gender-specific Female: Treatments designed for female patient needs.
𝐁𝐲 𝐃𝐢𝐬𝐭𝐫𝐢𝐛𝐮𝐭𝐢𝐨𝐧 𝐂𝐡𝐚𝐧𝐧𝐞𝐥
This segment explains how products reach healthcare providers and patients.
• Direct Sales: Manufacturers supply products directly to medical facilities.
• Online Retail: Enables digital purchasing and product access.
• Dealerships: Act as regional sales and service partners.
• Distributors and Wholesalers: Manage large-scale product distribution.
𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬
The market is competitive, with companies focusing on product innovation and expanding treatment availability.
• Apollo Endosurgery Inc.: Develops minimally invasive weight loss solutions.
• Obalon Therapeutics Inc.: Focuses on swallowable gastric balloon systems.
• Allurion Technologies Inc.: Specializes in non-surgical gastric balloon treatments.
• Spatz FGIA: Offers adjustable gastric balloon technologies.
• ReShape Medical Inc.: Provides integrated weight loss solutions.
Companies are focusing on innovation, product improvement, and expanding clinical adoption.
𝐑𝐞𝐠𝐢𝐨𝐧𝐚𝐥 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬
The market shows steady growth across major global regions.
• North America: Driven by high obesity prevalence and strong healthcare infrastructure.
• Europe: Supported by increasing awareness of non-surgical weight loss options.
• Asia-Pacific: Growing due to rising obesity levels and improving healthcare access.
• Latin America: Gradual growth with increasing focus on weight management.
• Middle East & Africa: Developing steadily with expanding healthcare services.
𝐈𝐧𝐟𝐨𝐫𝐦𝐚𝐭𝐢𝐨𝐧 𝐒𝐨𝐮𝐫𝐜𝐞: https://www.valuemarketresearch.com/repo...oon-market